Penicillin minimum inhibitory concentration drift in identical sequential Streptococcus pneumoniae isolates from colonized healthy infants

Screening of the Leaf Extracts of Culinary Herbs (Apium graveolens, Petroselinum crispum, Cichorium endivia, and Anethum graveolens) for Their Antibacterial Activity Against Escherichia coli

INTRODUCTION

In the current era, infectious diseases pose a significant global challenge, primarily attributed to the widespread and prolonged use of antibiotics, which develop antimicrobial resistance. A significant proportion of pharmaceutical agents utilized globally can be traced back to plant origins, constituting approximately 25%. Medicinal applications harness a wide spectrum of plant-derived components, including flowers, leaves, stems, fruits, roots, waxes, oils, bioactive compounds, phytochemicals, and various other constituents.

MATERIALS AND METHODS

Our experiment evaluated the antibacterial activity of four different culinary plant leaf extracts. These extracts were prepared using four different solvents and were investigated against the gram-negative bacteria Escherichia coli DH5α using agar well diffusion and agar disc diffusion methods by measuring the zone of inhibition.

RESULTS

The aqueous extract of all leaves did not show any antibacterial activity, likely due to poor diffusion due to the formation of a precipitate. Conversely, Cichorium endivia has shown the highest antibacterial activity in isopropanol as compared to other herbs. Among the herbs examined, organic extracts from endives and soybeans have demonstrated notably strong antibacterial activity compared to the other herbs.

CONCLUSION

Conducting a systematic screening of leaf extracts from various culinary herbs to assess their antibacterial effectiveness against E. coli has produced encouraging and noteworthy results. In the investigation of various herbs, organic extracts derived from endives and soybeans have exhibited particularly robust antibacterial efficacy when compared to other herbal extracts.

Nasopharyngeal colonization with heptavalent pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae with prolonged vaccine dosing intervals

INTRODUCTION

Universal infant heptavalent pneumococcal conjugate vaccine (PCV-7) immunization, dosed near to the originally recommended schedule of a 3-dose series in the first 6 months of life, then a booster between 12 and 15 months, should reduce nasopharyngeal (NP) carriage of Streptococcus pneumoniae (Spn) PCV-7 types. The reduced availability of PCV-7 altered immunization schedules, particularly for third and fourth PCV-7 doses. We evaluated NP colonization in relation to originally recommended intervals and numbers of PCV-7 doses.

METHODS

Spn from NP cultures of a cohort of 106 normal children, obtained during 20 months of PCV-7 shortage, were identified and serotyped by standard methods.

RESULTS

Spn was detected in 153 of 418 cultures (37%). Age, >1 sibling, day-care attendance and prolonged PCV-7 dosing intervals were univariate risks for NP detection of PCV-7 types. PCV-7 strains comprised 7 of 15 (47%) of Spn before the first dose, 28 of 36 (78%) and 27 of 41 (66%), respectively, after the first and second dose and then 16 of 36 (44%) and 11 of 25 (44%) after the third and fourth doses. The risk of NP colonization with PCV-7 types was higher with intervals of >3 months between second and third doses and intervals of >8 months between the third and fourth doses. Multivariate analysis showed prolonged interval after the second and third PCV-7 doses and day-care attendance as risk factors for NP detection of PCV-7 strains.

CONCLUSION

Although PCV-7 serotypes were detected less after third and fourth PCV-7 doses, longer dosing intervals, particularly in day-care attendees, were associated with higher risk of PCV-7 detection in the NP.

In vivo penicillin MIC drift to extremely high resistance in Serotype 14 Streptococcus pneumoniae persistently colonizing the nasopharynx of an infant with chronic suppurative lung disease: a case study

This is the first report of in vivo pneumococcal penicillin MIC drift from 4.0 to 16.0 mg/liter, possibly associated with alterations in the pbp1a gene. The case presented here is of an infant with early onset recurrent pneumonia and chronic bronchitis requiring repeated antibiotics.

Beta-lactam resistance: clinical implications for pediatric patients

The emergence of resistance to established antibiotic agents such as beta-lactams has been reported worldwide and poses a serious challenge to the management of pediatric infections. The most common mechanism of resistance involves the production of an enzyme that inactivates the antibiotic before it can be effective. Streptococcus pneumoniae, the most common cause of pediatric respiratory tract infections, exhibits variable resistance to penicillins and aminopenicillin due to alterations in its penicillin-binding proteins (PBPs). Haemophilus influenzae and Moraxella catarrhalis show moderate and high beta-lactamase-mediated resistance to aminopenicillins, although they remain susceptible to beta-lactam/beta-lactamase inhibitor combinations. Methicillin-resistant Staphylococcus aureus, a frequent cause of skin and soft-tissue infections, has shown PBP-mediated beta-lactam resistance, prompting the wide-spread use of vancomycin to eradicate this pathogen. Finally, PBP-mediated resistance has been observed in a large proportion of isolates of coagulase-negative staphylococci, which account for a high proportion of nosocomial infections, particularly in neonatal intensive care units. The challenge is to control the emergence of beta-lactamase-mediated resistance by using beta-lactams judiciously. In this regard, the beta-lactam/beta-lactamase inhibitor combinations have an important role to play in extending the usefulness of established beta-lactam agents.